VOYA Investment Management
CTMX icon

VOYA Investment Management’s CytomX Therapeutics CTMX Stock Holding History

VOYA Investment Management’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$126K Buy
+33,686
New +$129K ﹤0.01% 2327
2022
Q2 		– Sell
-25,786
Closed -$69K – 2797
2022
Q1 		$69K Sell
25,786
-545
-2% -$2.09K ﹤0.01% 2560
2021
Q4 		$114K Sell
26,331
-158
-0.6% -$926 ﹤0.01% 2650
2021
Q3 		$134K Buy
26,489
+188
+0.7% +$1.01K ﹤0.01% 2676
2021
Q2 		$166K Buy
26,301
+2,579
+11% +$20.1K ﹤0.01% 2657
2021
Q1 		$183K Buy
23,722
+4,118
+21% +$32.6K ﹤0.01% 2566
2020
Q4 		$128K Buy
19,604
+4,007
+26% +$28.6K ﹤0.01% 2515
2020
Q3 		$104K Hold
15,597
– – ﹤0.01% 2333
2020
Q2 		$130K Sell
15,597
-7,602
-33% -$70.6K ﹤0.01% 2286
2020
Q1 		$178K Hold
23,199
– – ﹤0.01% 2168
2019
Q4 		$193K Buy
23,199
+3,852
+20% +$26K ﹤0.01% 2384
2019
Q3 		$143K Hold
19,347
– – ﹤0.01% 2320
2019
Q2 		$217K Buy
19,347
+1,306
+7% +$13.7K ﹤0.01% 2258
2019
Q1 		$194K Hold
18,041
– – ﹤0.01% 2278
2018
Q4 		$272K Buy
18,041
+1,862
+12% +$27.6K ﹤0.01% 2084
2018
Q3 		$299K Buy
16,179
+1,223
+8% +$27.9K ﹤0.01% 2149
2018
Q2 		$342K Buy
14,956
+1,868
+14% +$47.7K ﹤0.01% 2069
2018
Q1 		$372K Hold
13,088
– – ﹤0.01% 1982
2017
Q4 		$276K Hold
13,088
– – ﹤0.01% 2183
2017
Q3 		$238K Hold
13,088
– – ﹤0.01% 2299
2017
Q2 		$203K Buy
+13,088
New +$197K ﹤0.01% 2403

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

VOYA Investment Management's CTMX Position: Q2 2026 in Review

VOYA Investment Management opened a new position in CytomX Therapeutics (CTMX) in Q2 2026: 33,686 shares worth $126K. The stake represents ﹤0.01% of the portfolio and ranks #2327 among its holdings. This is a return to the name: VOYA Investment Management previously reported a position in CTMX as recently as Q1 2022.

VOYA Investment Management first reported a position in CTMX in Q2 2017 and has held it in 21 quarters since. The position peaked at $372K in Q1 2018. 178 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

  • VOYA Investment Management held 33,686 shares of CytomX Therapeutics worth $126K as of Q2 2026.
  • CytomX Therapeutics was a new VOYA Investment Management position in Q2 2026.
  • CytomX Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2327 holding.
  • VOYA Investment Management first reported a position in CytomX Therapeutics in Q2 2017 and has held it in 21 quarters since.
  • VOYA Investment Management's CytomX Therapeutics position peaked at $372K in Q1 2018.
  • 178 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.